CoChat

Progress in PET Imaging of Neuroinflammation Targeting COX-2 Enzyme

Open access

The DOI matches its Crossref record; 61 of the 64 references it cites were found in a registry or an index.

Abstract

Neuroinflammation and cyclooxygenase-2 (COX-2) upregulation are associated with the pathogenesis of degenerative brain diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), epilepsy, and a response to traumatic brain injury (TBI) or stroke. COX-2 is also induced in acute pain, depression, schizophrenia, various cancers, arthritis and in acute allograft rejection. Positron emission tomography (PET) imaging allows for the direct measurement of in vivo COX-2 upregulation and thereby enables disease staging, therapy evaluation and aid quantifying target occupancy of novel nonsteroidal anti-inflammatory drugs or NSAIDs. Thus far, no clinically useful radioligand is established for monitoring COX-2 induction in brain diseases due to the delay in identifying qualified COX-2-selective inhibitors entering the brain. This review examines radiolabeled COX-2 inhibitors reported in the past decade and identifies the most promising radioligands for development as clinically useful PET radioligands. Among the radioligands reported so far, the three tracers that show potential for clinical translation are, [11CTMI], [11C]MC1 and [18F]MTP. These radioligands demonstrated BBB permeablity and in vivo binding to constitutive COX-2 in the brain or induced COX-2 during neuroinflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules26113208

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 COX-2 mediated conversion of arachidonic acid into prostaglandin H2 (PGH2) and subsequent conversion of PGH2 into different eicosanoids.
Figure 1 COX-2 mediated conversion of arachidonic acid into prostaglandin H2 (PGH2) and subsequent conversion of PGH2 into different eicosanoids.CC BY · PubMed Central
Figure 2 (a) MRI and summed (0–120 min) PET images of [11C]TMI in healthy baboon: (b) total volume of distribution (VTs) in baboon brain, baseline and blocking, estimated using a one-tissue compartment (1TC), Logan plot and likelihood estimation in graphical analysis (LEGA) methods. CIN: cingulate cortex; CER: cerebellum; FRT: frontal cortex; HIP: hippocampus; ORB: orbital cortex; THA: thalamus.
Figure 2 (a) MRI and summed (0–120 min) PET images of [11C]TMI in healthy baboon: (b) total volume of distribution (VTs) in baboon brain, baseline and blocking, estimated using a one-tissue compartment (1TC), Logan plot and likelihood estimation in graphical analysis (LEGA) methods. CIN: cingulate cortex; CER: cerebellum; FRT: frontal cortex; HIP: hippocampus; ORB: orbital cortex; THA: thalamus.CC BY · PubMed Central
Figure 3 Representative microPET images of [18F]MTP in PBS- and LPS-administered mice (a); TACs of [18F]MTP in PBS- (green) and LPS (red)-treated mice (b).
Figure 3 Representative microPET images of [18F]MTP in PBS- and LPS-administered mice (a); TACs of [18F]MTP in PBS- (green) and LPS (red)-treated mice (b).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. Pal, 2018, Incidence and Prevalence of Major Neurologic Disorders, Neurology, 43, 24
  2. Cortes, 2015, Synthesis of PET radioligands as potential probes for imaging COX-2 in neuroinflammation, J. Nucl. Med., 56, 1092

Cited by

See all 85

Metadata

Authors
Prabhakaran, J., Molotkov, A., Mintz, A., & Mann, J. J.
Affiliations
Columbia University Irving Medical Center (US)
Corresponding author
Prabhakaran, Jaya
Venue
Molecules
Publisher
MDPI AG
Published
2021-05-27
Volume
26
Issue
11
Pages
3208
ISSN
1420-3049 (ISSN-L)
OpenAlex
W3165497367
Cited by
74
References
64
Citations by year
2026: 6 · 2025: 17 · 2024: 15 · 2023: 22 · 2022: 12 · 2021: 2
FWCI
2.08
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institutes of Health (R01AG070042)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
neuroinflammation, cyclooxygenase-2, PET radiotracer, COX-2 inhibitors, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, traumatic brain injury, stroke, nonsteroidal anti-inflammatory drugs, target occupancy
MeSH terms
Celecoxib, Animals, Anti-Inflammatory Agents, Blood-Brain Barrier, Brain, Central Nervous System Diseases, Chemistry, Pharmaceutical, Female, Humans, Inflammation, Kinetics, Ligands, Magnetic Resonance Imaging, Male, Papio, Permeability, Positron-Emission Tomography, Mice, Rats, Cyclooxygenase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.